Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Outstanding Awards and Exercises (Details)

v3.23.1
Stock-Based Compensation - Outstanding Awards and Exercises (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Awards | Common Class A, Class B And Class C  
Compensation cost not yet recognized  
Shares reserved for future issuance upon exercise of stock options 3,900,000
Options  
Compensation cost not yet recognized  
Unrecognized compensation cost options | $ $ 45
Period over which unrecognized compensation cost will be recognized 1 year 4 months 24 days
Options | Series A common stock  
Options  
Options granted (in shares) 0
Outstanding ending balance (in shares) 0
Options | Series B common stock  
Options  
Options granted (in shares) 0
Forfeited/Cancelled (in shares) (69,000)
Outstanding ending balance (in shares) 246,000
WAEP  
WAEP options forfeited/cancelled (in dollars per share) | $ / shares $ 97.21
WAEP Outstanding ending balance (in dollars per share) | $ / shares $ 95.98
Options additional disclosures  
Weighted average remaining contractual life outstanding 1 year 6 months
Options | Series C common stock  
Options  
Outstanding beginning balance (in shares) 3,602,000
Options granted (in shares) 129,000
Exercised (in shares) (24,000)
Forfeited/Cancelled (in shares) (29,000)
Outstanding ending balance (in shares) 3,678,000
Number of awards exercisable (in shares) 2,382,000
WAEP  
WAEP Outstanding beginning balance (in dollars per share) | $ / shares $ 98.62
WAEP Options granted (in dollars per share) | $ / shares 80.19
WAEP options exercised (in dollars per share) | $ / shares 67.24
WAEP options forfeited/cancelled (in dollars per share) | $ / shares 96.49
WAEP Outstanding ending balance (in dollars per share) | $ / shares 98.19
WAEP options exercisable (in dollars per share) | $ / shares $ 77.46
Options additional disclosures  
Weighted average remaining contractual life outstanding 3 years 3 months 18 days
Weighted average remaining contractual life exercisable 2 years 7 months 6 days
Aggregate intrinsic value outstanding | $ $ 51
Aggregate intrinsic value exercisable | $ $ 51
Options | CEO | Series C common stock  
Options  
Options granted (in shares) 129,000